Trials / Completed
CompletedNCT02410083
Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent
Multicenter, Randomized, Open Study, Investigator-initiated Trial for Comparison of Eight Weeks Efficacy and Tolerability of Clopirin and Clopidogrel With Aspirin in Korean Patients With Post-Percutaneous Coronary Artery Intervention
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 448 (actual)
- Sponsor
- Jeil Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study in to evaluate efficacy and tolerability of Clopirin and clopidogrel with aspirin in Korean Patients with post-percutaneous coronary artery intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clopirin 1 | |
| DRUG | Clopidogrel-Aspirin(co-administration) 1 | |
| DRUG | Clopirin 2 | |
| DRUG | Clopidogrel-Aspirin(co-administration) 2 |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-04-01
- Completion
- 2015-12-01
- First posted
- 2015-04-07
- Last updated
- 2017-03-14
Source: ClinicalTrials.gov record NCT02410083. Inclusion in this directory is not an endorsement.